Rapid Response of Palmoplantar Psoriasis to Risankizumab: A Case Report
Abdullah Muqrin Al Muqrin,1 Abdulaziz A Alghamdi,1 Ziad M AlShaalan2 1Dermatology, Prince Mohammed Medical City, Skaka, AlJouf, Saudi Arabia; 2Department of Internal Medicine, College of Medicine, Jouf University, Skakak, AlJouf, Saudi ArabiaCorrespondence: Abdullah Muqrin Al Muqrin, Dermatology, Pr...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-10-01
|
Series: | Clinical, Cosmetic and Investigational Dermatology |
Subjects: | |
Online Access: | https://www.dovepress.com/rapid-response-of-palmoplantar-psoriasis-to-risankizumab-a-case-report-peer-reviewed-fulltext-article-CCID |
_version_ | 1817980601546833920 |
---|---|
author | Al Muqrin AM Alghamdi AA AlShaalan ZM |
author_facet | Al Muqrin AM Alghamdi AA AlShaalan ZM |
author_sort | Al Muqrin AM |
collection | DOAJ |
description | Abdullah Muqrin Al Muqrin,1 Abdulaziz A Alghamdi,1 Ziad M AlShaalan2 1Dermatology, Prince Mohammed Medical City, Skaka, AlJouf, Saudi Arabia; 2Department of Internal Medicine, College of Medicine, Jouf University, Skakak, AlJouf, Saudi ArabiaCorrespondence: Abdullah Muqrin Al Muqrin, Dermatology, Prince Mohammed Medical City, Skaka City, 72345, AlJouf, Saudi Arabia, Tel +96654777446, Email Abdullah.mq4@outlook.comAbstract: Palmoplantar psoriasis, a clinical variant of plaque psoriasis, has a significant impact by causing deterioration in the social and functional aspects of patients’ lives. Numerous therapeutic interventions are available for palmoplantar psoriasis. Although emerging biological agents have had an enormous positive impact on chronic plaque psoriasis, studies assessing their effectiveness in the palmoplantar phenotype are limited in the literature. We therefore present a case report of a patient with a 10-year history of palmoplantar psoriasis, which has significantly impacted her occupational life. She was treated with Risankizumab, showing a significant and rapid improvement in her symptoms. We believe that Risankizumab could be one of the most effective therapeutic interventions in the clinical context where rapid clearance of palmoplantar psoriasis is required.Keywords: psoriasis, Risankizumab, palmoplantar, rapid onset, biologic, biological agent |
first_indexed | 2024-04-13T22:55:31Z |
format | Article |
id | doaj.art-12302e83e59a4a54b07cd04d16210c86 |
institution | Directory Open Access Journal |
issn | 1178-7015 |
language | English |
last_indexed | 2024-04-13T22:55:31Z |
publishDate | 2022-10-01 |
publisher | Dove Medical Press |
record_format | Article |
series | Clinical, Cosmetic and Investigational Dermatology |
spelling | doaj.art-12302e83e59a4a54b07cd04d16210c862022-12-22T02:26:02ZengDove Medical PressClinical, Cosmetic and Investigational Dermatology1178-70152022-10-01Volume 152129213278723Rapid Response of Palmoplantar Psoriasis to Risankizumab: A Case ReportAl Muqrin AMAlghamdi AAAlShaalan ZMAbdullah Muqrin Al Muqrin,1 Abdulaziz A Alghamdi,1 Ziad M AlShaalan2 1Dermatology, Prince Mohammed Medical City, Skaka, AlJouf, Saudi Arabia; 2Department of Internal Medicine, College of Medicine, Jouf University, Skakak, AlJouf, Saudi ArabiaCorrespondence: Abdullah Muqrin Al Muqrin, Dermatology, Prince Mohammed Medical City, Skaka City, 72345, AlJouf, Saudi Arabia, Tel +96654777446, Email Abdullah.mq4@outlook.comAbstract: Palmoplantar psoriasis, a clinical variant of plaque psoriasis, has a significant impact by causing deterioration in the social and functional aspects of patients’ lives. Numerous therapeutic interventions are available for palmoplantar psoriasis. Although emerging biological agents have had an enormous positive impact on chronic plaque psoriasis, studies assessing their effectiveness in the palmoplantar phenotype are limited in the literature. We therefore present a case report of a patient with a 10-year history of palmoplantar psoriasis, which has significantly impacted her occupational life. She was treated with Risankizumab, showing a significant and rapid improvement in her symptoms. We believe that Risankizumab could be one of the most effective therapeutic interventions in the clinical context where rapid clearance of palmoplantar psoriasis is required.Keywords: psoriasis, Risankizumab, palmoplantar, rapid onset, biologic, biological agenthttps://www.dovepress.com/rapid-response-of-palmoplantar-psoriasis-to-risankizumab-a-case-report-peer-reviewed-fulltext-article-CCIDpsoriasisrisankizumabpalmoplantarrapid onsetbiologicbiological agent. |
spellingShingle | Al Muqrin AM Alghamdi AA AlShaalan ZM Rapid Response of Palmoplantar Psoriasis to Risankizumab: A Case Report Clinical, Cosmetic and Investigational Dermatology psoriasis risankizumab palmoplantar rapid onset biologic biological agent. |
title | Rapid Response of Palmoplantar Psoriasis to Risankizumab: A Case Report |
title_full | Rapid Response of Palmoplantar Psoriasis to Risankizumab: A Case Report |
title_fullStr | Rapid Response of Palmoplantar Psoriasis to Risankizumab: A Case Report |
title_full_unstemmed | Rapid Response of Palmoplantar Psoriasis to Risankizumab: A Case Report |
title_short | Rapid Response of Palmoplantar Psoriasis to Risankizumab: A Case Report |
title_sort | rapid response of palmoplantar psoriasis to risankizumab a case report |
topic | psoriasis risankizumab palmoplantar rapid onset biologic biological agent. |
url | https://www.dovepress.com/rapid-response-of-palmoplantar-psoriasis-to-risankizumab-a-case-report-peer-reviewed-fulltext-article-CCID |
work_keys_str_mv | AT almuqrinam rapidresponseofpalmoplantarpsoriasistorisankizumabacasereport AT alghamdiaa rapidresponseofpalmoplantarpsoriasistorisankizumabacasereport AT alshaalanzm rapidresponseofpalmoplantarpsoriasistorisankizumabacasereport |